Global Nuclear Medicine/Radiopharmaceuticals Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Driven by the downstream end-users, the market of Nuclear Medicine/Radiopharmaceuticals witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Nuclear Medicine/Radiopharmaceuticals market is offered. The research provides insights for the global Nuclear Medicine/Radiopharmaceuticals market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Nuclear Medicine/Radiopharmaceuticals industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Nuclear Medicine/Radiopharmaceuticals Market Segmentations:

    By Players:

    • Eli Lilly

    • Dongcheng

    • Triad Isotopes

    • Jubilant Pharma

    • Siemens

    • China Isotope & Radiation

    • Bracco Imaging

    • Nordion

    • Bayer

    • Mallinckrodt

    • GE Healthcare

    • Lantheus Medical Imaging


    By Types:

    • Diagnostic

    • Therapeutic


    By End-User:

    • Oncology

    • Thyroid

    • Cardiology

    • Other


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Nuclear Medicine/Radiopharmaceuticals Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Nuclear Medicine/Radiopharmaceuticals Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine/Radiopharmaceuticals Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by Types

      • 1.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Diagnostic from 2013 to 2025

      • 1.3.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Share by End-Users

      • 1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2013 to 2025

      • 1.4.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2013 to 2025

      • 1.4.4 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2013 to 2025

      • 1.4.5 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Other from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumNuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Nuclear Medicine/Radiopharmaceuticals Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine/Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic

      • 3.4.2 Market Size and Growth Rate of Therapeutic


    4 Segmentation of Nuclear Medicine/Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine/Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals for Oncology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals for Thyroid

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals for Cardiology

      • 4.4.4 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceuticals for Other


    5 Market Analysis by Major Regions

    • 5.1 Global Nuclear Medicine/Radiopharmaceuticals Production Analysis by Major Regions

    • 5.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Analysis by Major Regions

    • 5.3 Global Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis


    6 Product Commodity of Nuclear Medicine/Radiopharmaceuticals Market in Major Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 7.1 North America Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 North America Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 7.3 North America Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Countries

      • 7.3.1 United States Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 7.3.2 Canada Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 7.3.3 Mexico Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate


    8 Europe Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 8.1 Europe Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Europe Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 8.3 Europe Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Countries

      • 8.3.1 Germany Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.2 UK Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.3 France Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.4 Italy Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.6 Spain Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.7 Belgium Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.8 Poland Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.9 Russia Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 8.3.10 Turkey Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate


    9 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 9.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Countries

      • 9.3.1 China Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.4 India Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 9.3.6 South Korea Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.2 Brazil Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.3 Nigeria Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

      • 10.3.4 South Africa Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate 

      • 10.3.5 Argentina Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Eli Lilly

      • 11.1.1 Eli Lilly Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Dongcheng

      • 11.2.1 Dongcheng Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Triad Isotopes

      • 11.3.1 Triad Isotopes Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Jubilant Pharma

      • 11.4.1 Jubilant Pharma Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Siemens

      • 11.5.1 Siemens Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 China Isotope & Radiation

      • 11.6.1 China Isotope & Radiation Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Bracco Imaging

      • 11.7.1 Bracco Imaging Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Nordion

      • 11.8.1 Nordion Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Bayer

      • 11.9.1 Bayer Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Mallinckrodt

      • 11.10.1 Mallinckrodt Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 GE Healthcare

      • 11.11.1 GE Healthcare Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Lantheus Medical Imaging

      • 11.12.1 Lantheus Medical Imaging Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 92 Figures and 146 Tables)

    • Figure Product Picture

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Diagnostic from 2013 to 2025

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2013 to 2025

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Thyroid from 2013 to 2025

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2013 to 2025

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate of Other from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Nuclear Medicine/Radiopharmaceuticals Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine/Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine/Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine/Radiopharmaceuticals by Different Types from 2013 to 2025

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceuticals by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Diagnostic

    • Figure Market Size and Growth Rate of Therapeutic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine/Radiopharmaceuticals by Different End-Users from 2013 to 2025

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceuticals by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Thyroid

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Other

    • Table Global Nuclear Medicine/Radiopharmaceuticals Production by Major Regions

    • Table Global Nuclear Medicine/Radiopharmaceuticals Production Share by Major Regions

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Production Share by Major Regions in 2013

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Production Share by Major Regions in 2018

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Production Share by Major Regions in 2025

    • Table Global Nuclear Medicine/Radiopharmaceuticals Consumption by Major Regions

    • Table Global Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Regions

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Regions in 2013

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Regions in 2018

    • Figure Global Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Regions in 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine/Radiopharmaceuticals market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2013 to 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2013

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2013

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2013

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure North America Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2025

    • Figure United States Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2013 to 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2013

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2013

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Europe Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2025

    • Figure Germany Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure France Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2013

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2013

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2025

    • Figure China Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandNuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure India Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Share by Major Countries in 2025

    • Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Nuclear Medicine/Radiopharmaceuticals Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Siemens

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens

    • Figure Sales and Growth Rate Analysis of Siemens

    • Figure Revenue and Market Share Analysis of Siemens

    • Table Product and Service Introduction of Siemens

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Lantheus Medical Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Product and Service Introduction of Lantheus Medical Imaging


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.